BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31060119)

  • 1. Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study.
    Lee HJ; Cho CM; Heo J; Jung MK; Kim TN; Kim KH; Kim H; Cho KB; Kim HG; Han J; Lee DW; Lee YS
    Gut Liver; 2020 Mar; 14(2):257-264. PubMed ID: 31060119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an Online App to Predict Post-Endoscopic Retrograde Cholangiopancreatography Adverse Events Using a Single-Center Retrospective Cohort.
    Rodrigues-Pinto E; Morais R; Sousa-Pinto B; Ferreira da Silva J; Costa-Moreira P; Santos AL; Silva M; Coelho R; Gaspar R; Peixoto A; Dias E; Baron TH; Vilas-Boas F; Moutinho-Ribeiro P; Pereira P; Macedo G
    Dig Dis; 2021; 39(3):283-293. PubMed ID: 33429393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis.
    Keswani RN; Qumseya BJ; O'Dwyer LC; Wani S
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1866-1875.e3. PubMed ID: 28606848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
    Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary needle-knife fistulotomy for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Importance of the endoscopist's expertise level.
    Han SY; Baek DH; Kim DU; Park CJ; Park YJ; Lee MW; Song GA
    World J Clin Cases; 2021 Jun; 9(17):4166-4177. PubMed ID: 34141779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-ERCP pancreatitis: is the endoscopist's experience the major risk factor?
    Rabenstein T; Hahn EG
    JOP; 2002 Nov; 3(6):177-87. PubMed ID: 12432184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic retrograde cholangiopancreatography-related adverse events in Korea: A nationwide assessment.
    Jang DK; Kim J; Paik CN; Kim JW; Lee TH; Jang JY; Yoon SB; Lee JK
    United European Gastroenterol J; 2022 Feb; 10(1):73-79. PubMed ID: 34953054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immunosuppression in post-endoscopic retrograde cholangiopancreatography pancreatitis after liver transplantation: a retrospective analysis.
    Law R; Leal C; Dayyeh BA; Leise MD; Balderramo D; Baron TH; Cardenas A
    Liver Transpl; 2013 Dec; 19(12):1354-60. PubMed ID: 24115362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic retrograde cholangiopancreatography-related early perforations: A study of effects of procedure duration, complexity, and endoscopist experience.
    Aloysius M; Goyal H; Nikumbh T; Shah NJ; Hammoud GM; Mutha P; Joseph-Talreja M; John S; Aswath G; Wadhwa V; Thosani N
    World J Gastrointest Endosc; 2023 Nov; 15(11):641-648. PubMed ID: 38073762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist.
    Katsinelos P; Lazaraki G; Chatzimavroudis G; Gkagkalis S; Vasiliadis I; Papaeuthimiou A; Terzoudis S; Pilpilidis I; Zavos C; Kountouras J
    Ann Gastroenterol; 2014; 27(1):65-72. PubMed ID: 24714755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of ERCP related to case-volume.
    Syrén EL; Sandblom G; Enochsson L; Eklund A; Isaksson B; Österberg J; Eriksson S
    Surg Endosc; 2022 Jul; 36(7):5339-5347. PubMed ID: 34981237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients.
    Sawas T; Bazerbachi F; Haffar S; Cho WK; Levy MJ; Martin JA; Petersen BT; Topazian MD; Chandrasekhara V; Abu Dayyeh BK
    World J Gastroenterol; 2018 Nov; 24(41):4691-4697. PubMed ID: 30416316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of center and endoscopist ERCP volume on ERCP outcomes: a systematic review and meta-analysis.
    Teles de Campos S; Papaefthymiou A; Florou T; Facciorusso A; Arvanitakis M; Devière J; Gkolfakis P
    Gastrointest Endosc; 2023 Sep; 98(3):306-315.e14. PubMed ID: 37201726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial.
    Mariani A; Di Leo M; Giardullo N; Giussani A; Marini M; Buffoli F; Cipolletta L; Radaelli F; Ravelli P; Lombardi G; D'Onofrio V; Macchiarelli R; Iiritano E; Le Grazie M; Pantaleo G; Testoni PA
    Endoscopy; 2016 Jun; 48(6):530-5. PubMed ID: 26990509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgeon-performed endoscopic retrograde cholangiopancreatography. Outcomes of 2392 procedures at two tertiary care centers.
    Al-Mansour MR; Fung EC; Jones EL; Zayan NE; Wetzel TD; Martin Del Campo SE; Jalilvand AD; Suzo AJ; Dettorre RR; Fullerton JK; Meara MP; Mellinger JD; Narula VK; Hazey JW
    Surg Endosc; 2018 Jun; 32(6):2871-2876. PubMed ID: 29273876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse outcomes of endoscopic retrograde cholangiopancreatography.
    Freeman ML
    Rev Gastroenterol Disord; 2002; 2(4):147-68. PubMed ID: 12481167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study.
    Li J; Hu J; Li P; Wu Y; Wang Y; Ji M; Hua H; Ran W; Pan Y; Zhang S
    Chin Med J (Engl); 2022 Oct; 135(19):2319-2325. PubMed ID: 36103988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up to determine unplanned hospitalization and complications after endoscopic retrograde cholangiopancreatography.
    Chan E; Neeman T; Thomson A
    ANZ J Surg; 2018 Mar; 88(3):E142-E146. PubMed ID: 27905178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.